DOCSLIB.ORG

Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma Published OnlineFirst February 7, 2013; DOI: 10.1158/0008-5472.CAN-12-2086 Cancer Molecular and Cellular Pathobiology Research Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma Keqiang Zhang1, Kevin Chu1, Xiwei Wu3, Hanlin Gao4, Jinhui Wang4, Yate-Ching Yuan3,Sofia Loera2, Kimberley Ho1, Yafan Wang5, Warren Chow1, Frank Un1, Peiguo Chu2, and Yun Yen1,6 Abstract Fibroblast growth factor (FGF) receptor (FGFR) substrate 2 (FRS2) is an adaptor protein that plays a critical role in FGFR signaling. FRS2 is located on chromosome 12q13-15 that is frequently amplified in liposarcomas. The significance of FRS2 and FGFR signaling in high-grade liposarcomas is unknown. Herein, we first comparatively examined the amplification and expression of FRS2 with CDK4 and MDM2 in dedifferentiated liposarcoma (DDLS) and undifferentiated high-grade pleomorphic sarcoma (UHGPS). Amplification and expression of the three genes were identified in 90% to 100% (9–11 of 11) of DDLS, whereas that of FRS2, CDK4, and MDM2 were observed in 55% (41 of 75), 48% (36 of 75), and 44% (33/75) of clinically diagnosed UHGPS, suggesting that these "UHGPS" may represent DDLS despite lacking histologic evidence of lipoblasts. Immunohistochemical analysis of phosphor- ylated FRS2 protein indicated that the FGFR/FRS2 signaling axis was generally activated in about 75% of FRS2- positive high-grade liposarcomas. Moreover, we found that FRS2 and FGFRs proteins are highly expressed and functional in three high-grade liposarcoma cell lines: FU-DDLS-1, LiSa-2, and SW872. Importantly, the FGFR selective inhibitor NVP-BGJ-398 significantly inhibited the growth of FU-DDLS-1 and LiSa-2 cells with a concomitant suppression of FGFR signal transduction. Attenuation of FRS2 protein in FU-DDLS-1 and LiSa-2 cell lines decreased the phosphorylated extracellular signal–regulated kinase 1/2 and AKT and repressed cell proliferation. These findings indicate that analysis of FRS2 in combination with CDK4 and MDM2 will more accurately characterize pathologic features of high-grade liposarcomas. Activated FGFR/FRS2 signaling may play a functional role in the development of high-grade liposarcomas, therefore, serve as a potential therapeutic target. Cancer Res; 73(4); 1–10. Ó2012 AACR. Introduction angiogenesis, and metastasis in multiple cancer types includ- Fibroblast growth factor (FGF) receptor (FGFR) substrate 2 ing breast cancer, bladder cancer, multiple myeloma, hepato- (FRS2) is a member of the adaptor/scaffold protein family that cellular, and renal cell carcinoma. Clinical studies have also binds to receptor tyrosine kinases (RTK) including FGFR, the revealed that aberrant FGFR signaling is associated with poor – neurotrophin receptor, RET, and ALK, and is required for signal outcome of different human cancers (4 7). These observations transduction from FGFRs (1). The FGFR family of 4 RTKs, make FGFRs signaling increasingly attractive as target for FGFR1/2/3/4, mediate numerous physiologic processes therapeutic intervention in various human cancers (2). including cell migration, proliferation, survival, and differen- Liposarcomas are a heterogeneous group of mesenchymal tiation (2). Deregulation of FGFR signaling is associated with tumors, and on the basis of morphologic features and cyto- fi many developmental syndromes (3). Aberrant activation of genetic aberrations, liposarcoma is classi ed into 3 biologic FGFR signaling has been associated with tumor formation, types encompassing 5 subtypes: well-differentiated liposar- coma/dedifferentiated liposarcoma (WDLS/DDLS), myxoid/ round cell liposarcoma, and undifferentiated high-grade pleo- Authors' Affiliations: Departments of 1Molecular Pharmacology and morphic sarcoma (UHGPS; refs. 8–10). Surgery serves as the 2 3 Pathology; Division of Information Sciences of Department of Molecular mainstay of therapy for localized liposarcoma. However, for Medicine; 4Solexa Core Lab; 5Translational Research Laboratory, Beck- man Research Institute of the City of Hope National Medical Center, Duarte, locally advanced and disseminated disease, there are few California; and 6Taipei Medical University, Taipei, Taiwan effective treatment options (11). Liposarcomas with similar Note: Supplementary data for this article are available at Cancer Research morphologic appearance can follow different clinical courses Online (http://cancerres.aacrjournals.org/). and show divergent responses to systemic therapy (12, 13). K. Zhang and K. Chu contributed equally to this work. DDLS and UHGPS share similar histologic features, but com- pared with DDLS, UHGPS displays more aggressive local Corresponding Author: Yun Yen, Department of Molecular Pharmacolo- gy, Beckman Research Institute, City of Hope Comprehensive Cancer behavior and strong resistance to systemic ifosfamide-based Center, 1500 E. Duarte Road, Duarte, CA 91010. Phone: 626-256-4673, ext chemotherapy, resulting in a 5-year survival rate of about 50% 65707; Fax: 626-301-8233; E-mail: [email protected] (10). DDLS tends to have a lower metastatic rate (15%–20%) doi: 10.1158/0008-5472.CAN-12-2086 than UHGPS (30%–50%; ref. 12). However, the accurate dis- Ó2012 American Association for Cancer Research. crimination of pleomorphic from DDLS based on morphology www.aacrjournals.org OF1 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2013 American Association for Cancer Research. Published OnlineFirst February 7, 2013; DOI: 10.1158/0008-5472.CAN-12-2086 Zhang et al. alone is often a challenge even for an experienced soft-tissue in vitro growth of FU-DDLS-1 and LiSa-2 cells with a concom- pathologist. Recent reports indicate that "UHGPS" has been itant suppression of FGFR signal transduction. Our findings for misused for several better classifiable, poorly differentiated the first time indicate that activated FGFR/FRS2 signaling may soft-tissue sarcomas (14). For example, a study reported that contribute to the progression of high-grade liposarcomas, 23% of 163 high-grade liposarcomas in the Netherlands Cancer therefore representing a potential therapeutic target that Institute were reclassified on the basis of molecular character- deserves further extensive study. Recent advances in molecular istics of liposarcoma (15). Similarly, another study re-evaluated characterization of liposarcomas have shown that aberrant 159 cases of previously diagnosed UHGPS and found that a amplification of MDM2 and CDK4 genes within chromosome total of 97 of these cases could be reclassified as other sarcomas 12q13-15 distinguishes WDLS/DDLS from UHGPS (16–18). and 20 were proven to be nonmesenchymal neoplasms (16). Accordingly, we also validated that a subset of clinically During the past decade, with the insight afforded by immu- diagnosed "UHGPS" of current study may represent DDLS. nohistochemistry as well as improved cytogenetic and molec- Importantly, we observed that 7% of these "UHGPS" were ular diagnostics, the term UHGPS has been restricted to a immunopositive for FRS2 only. Our study also suggests that group of soft-tissue malignancies without a specific line of analysis of FRS2 in combination with CDK4 and MDM2 will differentiation (17). Therefore, it is critical to better classify and even more accurately classify high-grade liposarcomas and target various high-grade liposarcomas based on their specific lead to better prognostication. pathologic features. Amplification of MDM2 and CDK4 genes on chromosome Materials and Methods 12q13-15 is noted to frequently occur in WDLS/DDLS and may Cellular proliferation and FRS2 siRNA knockdown assays also serve as genetic characteristics of DDLS from UHGPS. For FU-DDLS-1 DDLS cell line was a kind gift from Dr. Hiroshi example, Taylor and colleagues, using high-resolution genomic Iwasaki (Fukuoka University, School of Medicine, Fukuoka, analysis, proved that there was no CDK4 amplification in Japan; ref. 23) and was maintained in Dulbeccos' Modified UHGPS (18). The chromosome 12q13-15 amplicon is discon- Eagle's Medium (DMEM):F12 medium with 10% FBS. SW872 tinuous and spans several megabases of DNA and contains DDLS cell line was purchased from the American Type Culture multiple genes (19). The discontinuous amplification may lead Collection and was cultured in DMEM with 10% FBS. LiSa-2 to the patterns for overexpressed proteins that may provide pleomorphic liposarcoma cell line was a kind gift from Dr. Silke growth advantages to tumors quite different between patients. Bruderlein (University of Ulm, Ulm, Germany; ref. 24) and was Among genes on chromosome 12q13-15, CDK4 gene, a cyclin- maintained in Iscove's modified Dulbecco's medium/RPMI in a dependent kinase promoting G1-phase cell-cycle progression, 4:1 ratio supplemented with 10% FBS, 2 mmol/L L-glutamine, and MDM2 gene, a transcriptional target of p53, which med- and 0.1 mg/mL gentamicin. All cells were newly DNA finger- iates both ubiquitin-dependent proteasomal degradation of printed to confirm identity as previously described (25). p53 and ubiquitin-independent proteasomal degradation of Human adipose tissue total RNA survey Lot #07505959A and p21, causing unchecked cell-cycle progression and prolifera- #0903009 were purchased from Ambion Inc. Human FRS2 tion, have been well-studied because of their critical function in gene–specific siRNA and scrambled siRNA (Life Technologies oncogenesis of liposarcoma (20, 21). The FRS2 gene is located Corporation) were transfected into cells with Lipofectamine close to CDK4 and MDM2 on chromosome 12q13-15. Most siRNA Maximum (Life Science, Inc.) according
Load more

Recommended publications
  • Src Activation Plays an Important Key Role in Lymphomagenesis Induced by FGFR1 Fusion Kinases
    Published OnlineFirst September 21, 2011; DOI: 10.1158/0008-5472.CAN-11-1109 Cancer Tumor and Stem Cell Biology Research Src Activation Plays an Important Key Role in Lymphomagenesis Induced by FGFR1 Fusion Kinases Mingqiang Ren, Haiyan Qin, Ruizhe Ren, Josephine Tidwell, and John K. Cowell Abstract Chromosomal translocations and activation of the fibroblast growth factor (FGF) receptor 1 (FGFR1) are a feature of stem cell leukemia–lymphoma syndrome (SCLL), an aggressive malignancy characterized by rapid transformation to acute myeloid leukemia and lymphoblastic lymphoma. It has been suggested that FGFR1 proteins lose their ability to recruit Src kinase, an important mediator of FGFR1 signaling, as a result of the translocations that delete the extended FGFR substrate-2 (FRS2) interacting domain that Src binds. In this study, we report evidence that refutes this hypothesis and reinforces the notion that Src is a critical mediator of signaling from the FGFR1 chimeric fusion genes generated by translocation in SCLL. Src was constitutively active in BaF3 cells expressing exogenous FGFR1 chimeric kinases cultured in vitro as well as in T-cell or B-cell lymphomas they induced in vivo. Residual components of the FRS2-binding site retained in chimeric kinases that were generated by translocation were sufficient to interact with FRS2 and activate Src. The Src kinase inhibitor dasatinib killed transformed BaF3 cells and other established murine leukemia cell lines expressing chimeric FGFR1 kinases, significantly extending the survival of mice with SCLL syndrome. Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.
    [Show full text]
  • FGF Signaling Network in the Gastrointestinal Tract (Review)
    163-168 1/6/06 16:12 Page 163 INTERNATIONAL JOURNAL OF ONCOLOGY 29: 163-168, 2006 163 FGF signaling network in the gastrointestinal tract (Review) MASUKO KATOH1 and MASARU KATOH2 1M&M Medical BioInformatics, Hongo 113-0033; 2Genetics and Cell Biology Section, National Cancer Center Research Institute, Tokyo 104-0045, Japan Received March 29, 2006; Accepted May 2, 2006 Abstract. Fibroblast growth factor (FGF) signals are trans- Contents duced through FGF receptors (FGFRs) and FRS2/FRS3- SHP2 (PTPN11)-GRB2 docking protein complex to SOS- 1. Introduction RAS-RAF-MAPKK-MAPK signaling cascade and GAB1/ 2. FGF family GAB2-PI3K-PDK-AKT/aPKC signaling cascade. The RAS~ 3. Regulation of FGF signaling by WNT MAPK signaling cascade is implicated in cell growth and 4. FGF signaling network in the stomach differentiation, the PI3K~AKT signaling cascade in cell 5. FGF signaling network in the colon survival and cell fate determination, and the PI3K~aPKC 6. Clinical application of FGF signaling cascade in cell polarity control. FGF18, FGF20 and 7. Clinical application of FGF signaling inhibitors SPRY4 are potent targets of the canonical WNT signaling 8. Perspectives pathway in the gastrointestinal tract. SPRY4 is the FGF signaling inhibitor functioning as negative feedback apparatus for the WNT/FGF-dependent epithelial proliferation. 1. Introduction Recombinant FGF7 and FGF20 proteins are applicable for treatment of chemotherapy/radiation-induced mucosal injury, Fibroblast growth factor (FGF) family proteins play key roles while recombinant FGF2 protein and FGF4 expression vector in growth and survival of stem cells during embryogenesis, are applicable for therapeutic angiogenesis. Helicobacter tissues regeneration, and carcinogenesis (1-4).
    [Show full text]
  • Integrated Genetic and Epigenetic Analysis Defines Novel Molecular
    ARTICLE Received 7 Jan 2015 | Accepted 20 May 2015 | Published 3 Jul 2015 DOI: 10.1038/ncomms8557 OPEN Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma Masafumi Seki1,*, Riki Nishimura1,*, Kenichi Yoshida2,3, Teppei Shimamura4,5, Yuichi Shiraishi4, Yusuke Sato2,3, Motohiro Kato1,6,7, Kenichi Chiba4, Hiroko Tanaka8, Noriko Hoshino9, Genta Nagae10, Yusuke Shiozawa2,3, Yusuke Okuno3,11, Hajime Hosoi12, Yukichi Tanaka13, Hajime Okita14, Mitsuru Miyachi12, Ryota Souzaki15, Tomoaki Taguchi15, Katsuyoshi Koh7, Ryoji Hanada7, Keisuke Kato16, Yuko Nomura17, Masaharu Akiyama18, Akira Oka1, Takashi Igarashi1,19, Satoru Miyano4,8, Hiroyuki Aburatani10, Yasuhide Hayashi20, Seishi Ogawa2,3 & Junko Takita1 Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/ or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS.
    [Show full text]
  • Flotillins in Receptor Tyrosine Kinase Signaling and Cancer
    Cells 2014, 3, 129-149; doi:10.3390/cells3010129 OPEN ACCESS cells ISSN 2073-4409 www.mdpi.com/journal/cells Review Flotillins in Receptor Tyrosine Kinase Signaling and Cancer Antje Banning, Nina Kurrle †, Melanie Meister and Ritva Tikkanen * Institute of Biochemistry, Medical faculty, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany; E-Mails: [email protected] (A.B.); [email protected] (N.K.); [email protected] (M.M.) † Present address: Department of Molecular Haematology, Goethe University Medical School, 60590 Frankfurt, Germany. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-641-9947-420; Fax: +49-641-9947-429. Received: 11 December 2013; in revised form: 11 February 2014 / Accepted: 12 February 2014/ Published: 19 February 2014 Abstract: Flotillins are highly conserved proteins that localize into specific cholesterol rich microdomains in cellular membranes. They have been shown to be associated with, for example, various signaling pathways, cell adhesion, membrane trafficking and axonal growth. Recent findings have revealed that flotillins are frequently overexpressed in various types of human cancers. We here review the suggested functions of flotillins during receptor tyrosine kinase signaling and in cancer. Although flotillins have been implicated as putative cancer therapy targets, we here show that great caution is required since flotillin ablation may result in effects that increase instead of decrease the activity of specific signaling pathways. On the other hand, as flotillin overexpression appears to be related with metastasis formation in certain cancers, we also discuss the implications of these findings for future therapy aspects.
    [Show full text]
  • Frs2 Enhances Fibroblast Growth Factor-Mediated Survival And
    RESEARCH ARTICLE 4601 Development 139, 4601-4612 (2012) doi:10.1242/dev.081737 © 2012. Published by The Company of Biologists Ltd Frs2 enhances fibroblast growth factor-mediated survival and differentiation in lens development Bhavani P. Madakashira1, Daniel A. Kobrinski1, Andrew D. Hancher1, Elizabeth C. Arneman1, Brad D. Wagner1, Fen Wang2, Hailey Shin3, Frank J. Lovicu3, Lixing W. Reneker4 and Michael L. Robinson1,* SUMMARY Most growth factor receptor tyrosine kinases (RTKs) signal through similar intracellular pathways, but they often have divergent biological effects. Therefore, elucidating the mechanism of channeling the intracellular effect of RTK stimulation to facilitate specific biological responses represents a fundamental biological challenge. Lens epithelial cells express numerous RTKs with the ability to initiate the phosphorylation (activation) of Erk1/2 and PI3-K/Akt signaling. However, only Fgfr stimulation leads to lens fiber cell differentiation in the developing mammalian embryo. Additionally, within the lens, only Fgfrs activate the signal transduction molecule Frs2. Loss of Frs2 in the lens significantly increases apoptosis and decreases phosphorylation of both Erk1/2 and Akt. Also, Frs2 deficiency decreases the expression of several proteins characteristic of lens fiber cell differentiation, including Prox1, p57KIP2, aquaporin 0 and -crystallins. Although not normally expressed in the lens, the RTK TrkC phosphorylates Frs2 in response to binding the ligand NT3. Transgenic lens epithelial cells expressing both TrkC and NT3 exhibit several features characteristic of lens fiber cells. These include elongation, increased Erk1/2 and Akt phosphorylation, and the expression of -crystallins. All these characteristics of NT3-TrkC transgenic lens epithelial cells depend on Frs2. Therefore, tyrosine phosphorylation of Frs2 mediates Fgfr-dependent lens cell survival and provides a mechanistic basis for the unique fiber-differentiating capacity of Fgfs on mammalian lens epithelial cells.
    [Show full text]
  • Genetic Insights Into the Mechanisms of Fgf Signaling
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Genetic insights into the mechanisms of Fgf signaling J. Richard Brewer, Pierre Mazot, and Philippe Soriano Department of Developmental and Regenerative Biology, Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai, New York, New York 10029, USA The fibroblast growth factor (Fgf) family of ligands and re- Fgf signaling is therefore important to appreciate many as- ceptor tyrosine kinases is required throughout embryonic pects of Fgf biology and disease. and postnatal development and also regulates multiple Many of the developmental functions of Fgf signaling homeostatic functions in the adult. Aberrant Fgf signaling seem to be conserved between mice and humans. This causes many congenital disorders and underlies multiple is evident by the striking phenotypic similarities between forms of cancer. Understanding the mechanisms that gov- human congenital disorders caused by alterations in ern Fgf signaling is therefore important to appreciate Fgf signaling and their corresponding mouse models. many aspects of Fgf biology and disease. Here we review Conserved developmental requirements have been dem- the mechanisms of Fgf signaling by focusing on genetic onstrated in skeletal growth, palate closure, limb pattern- strategies that enable in vivo analysis. These studies sup- ing, ear development, cranial suture ossification, neural port an important role for Erk1/2 as a mediator of Fgf sig- development, and the hair cycle (Hebert et al. 1994; Rous- naling in many biological processes but have also provided seau et al. 1994; Shiang et al. 1994; Wilkie et al. 1995; Par- strong evidence for additional signaling pathways in trans- tanen et al.
    [Show full text]
  • Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects
    G C A T T A C G G C A T genes Article Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects Teresa Płatek 1,*, Anna Polus 1, Joanna Góralska 1, Urszula Ra´zny 1 , Agnieszka Dziewo ´nska 1, Agnieszka Micek 2 , Aldona Dembi ´nska-Kie´c 1, Bogdan Solnica 1 and Małgorzata Malczewska-Malec 1 1 Department of Clinical Biochemistry, Jagiellonian University Medical College, 15a Kopernika Street, 31-501 Krakow, Poland; [email protected] (A.P.); [email protected] (J.G.); [email protected] (U.R.); [email protected] (A.D.); [email protected] (A.D.-K.); [email protected] (B.S.); [email protected] (M.M.-M.) 2 Department of Nursing Management and Epidemiology Nursing, Faculty of Health Sciences, Jagiellonian University Medical College, 25 Kopernika Street, 31-501 Krakow, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-12-424-87-87 Abstract: We hypothesised that epigenetics may play an important role in mediating fibroblast growth factor 21 (FGF21) resistance in obesity. We aimed to evaluate DNA methylation changes and miRNA pattern in obese subjects associated with high serum FGF21 levels. The study included 136 participants with BMI 27–45 kg/m2. Fasting FGF21, glucose, insulin, GIP, lipids, adipokines, miokines and cytokines were measured and compared in high serum FGF21 (n = 68) group to low Citation: Płatek, T.; Polus, A.; FGF21 (n = 68) group. Human DNA Methylation Microarrays were analysed in leukocytes from Góralska, J.; Ra´zny, U.; each group (n = 16).
    [Show full text]
  • Anaplastic Lymphoma Kinase Activates the Small Gtpase Rap1 Via the Rap1-Specific GEF C3G in Both Neuroblastoma and PC12 Cells
    Oncogene (2010) 29, 2817–2830 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00 www.nature.com/onc ORIGINAL ARTICLE Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells C Scho¨nherr1, H-L Yang2, M Vigny3, RH Palmer1 and B Hallberg1 1Department of Molecular Biology, Umea˚ University, Umea˚, Sweden; 2College of Biological Sciences and Biotechnology, Beijing Forestry University, Beijing, China and 3U839 INSERM/UPMC IFM, Paris, France Many different types of cancer originate from aberrant the result of a chromosomal translocation event that signaling from the anaplastic lymphoma kinase (ALK) places the C-terminal portion of ALK together with the receptor tyrosine kinase (RTK), arising through different N-terminal part of NPM (Morris et al., 1994; Shiota translocation events and overexpression. Further, activa- et al., 1994, 1995). A variety of ALK fusion proteins ting point mutations in the ALK domain have been recently have since been described in inflammatory myofibro- reported in neuroblastoma. To characterize signaling in the blastic tumors, non-small cell lung cancer, diffuse B-cell context of the full-length receptor, we have examined lymphomas and squamous cell carcinoma of the whether ALK is able to activate Rap1 and contribute esophagus (reviewed by Palmer et al., 2009). Together to differentiation/proliferation processes. We show that with the reported expression of ALK in a number of cell ALK activates Rap1 via the Rap1-specific guanine- lines and tumors, these findings suggest a function for nucleotide exchange factor C3G, which binds in a inappropriately activated ALK in oncogenic progres- constitutive complex with CrkL to activated ALK.
    [Show full text]
  • The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
    cancers Review The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis 1, 2, , 1, Stephen P. Ducray y , Karthikraj Natarajan y z, Gavin D. Garland z, 1, , 2,3, , Suzanne D. Turner * y and Gerda Egger * y 1 Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB20QQ, UK 2 Department of Pathology, Medical University Vienna, 1090 Vienna, Austria 3 Ludwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria * Correspondence: [email protected] (S.D.T.); [email protected] (G.E.) European Research Initiative for ALK-related malignancies; www.erialcl.net. y These authors contributed equally to this work. z Received: 7 June 2019; Accepted: 23 July 2019; Published: 30 July 2019 Abstract: Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in neuronal and gut development. Initially discovered in T cell lymphoma, ALK is frequently affected in diverse cancers by oncogenic translocations. These translocations involve different fusion partners that facilitate multimerisation and autophosphorylation of ALK, resulting in a constitutively active tyrosine kinase with oncogenic potential. ALK fusion proteins are involved in diverse cellular signalling pathways, such as Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus protein tyrosine kinase (JAK)/STAT. Furthermore, ALK is implicated in epigenetic regulation, including DNA methylation and miRNA expression, and an interaction with nuclear proteins has been described. Through these mechanisms, ALK fusion proteins enable a transcriptional programme that drives the pathogenesis of a range of ALK-related malignancies. Keywords: ALK; ALCL; NPM-ALK; EML4-ALK; NSCLC; ALK-translocation proteins; epigenetics 1. Introduction Anaplastic lymphoma kinase (ALK) was first successfully cloned in 1994 when it was reported in the context of a fusion protein in cases of anaplastic large cell lymphoma (ALCL) [1].
    [Show full text]
  • FRS2-Dependent SRC Activation Is Required for Fibroblast Growth Factor
    Research Article 6007 FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity Xuan Li1, Valerie G. Brunton2, Helen R. Burgar1, Lee M. Wheldon1 and John K. Heath1,* 1CR-UK Growth Factor Group, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK 2CR-UK Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK *Author for correspondence (e-mail: [email protected]) Accepted 1 September 2004 Journal of Cell Science 117, 6007-6017 Published by The Company of Biologists 2004 doi:10.1242/jcs.01519 Summary Activation of signalling by fibroblast growth factor dependent upon FRS2 and fibroblast growth factor receptor leads to phosphorylation of the signalling receptor kinase activity. SRC forms a complex with attenuator human Sprouty 2 (hSpry2) on residue Y55. This hSpry2 and this interaction is enhanced by hSpry2 event requires the presence of the signalling adaptor phosphorylation. Phosphorylation of hSpry2 is required fibroblast growth factor receptor substrate 2 (FRS2). The for hSpry2 to inhibit activation of the extracellular signal- phosphorylation of hSpry2 is therefore mediated by an regulated kinase pathway. These results show that intermediate kinase. Using a SRC family kinase-specific recruitment of SRC to FRS2 leads to activation of signal inhibitor and mutant cells, we show that hSpry2 is a direct attenuation pathways. substrate for SRC family kinases, including SRC itself. Activation of SRC via fibroblast growth factor signalling is Key words: FGFR, FRS2, Sprouty, SRC, ERK Introduction 2000; Ong et al., 2000). FRS2 comprises a receptor recognition A major question in growth factor action is how signalling domain of the phosphotyrosine binding (PTB) class (Ong et dynamics are controlled by the components of the activated al., 2000) – which constitutively associates with the juxta- receptor complex (Yamada et al., 2004).
    [Show full text]
  • FRS2 Is an Oncogene in High Grade Ovarian Cancer
    FRS2 Is an Oncogene in High Grade Ovarian Cancer The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Luo, Leo Y. 2015. FRS2 Is an Oncogene in High Grade Ovarian Cancer. Doctoral dissertation, Harvard Medical School. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:15821602 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Abstract Ovarian cancer is the most common cause of gynecologic cancer death in the United States. Despite aggressive surgical cytoreduction and chemotherapy, ovarian cancer remains one of the most lethal cancer types due to advanced stages at diagnosis and lack of effective systemic therapy. High-grade serous ovarian cancers (HGSOC) are characterized by widespread recurrent regions of copy number gain and loss. Here we interrogated 50 genes that are recurrently amplified in HGSOC and essential for cancer proliferation and survival in ovarian cancer cell lines. FRS2 is one of the 50 genes located on chromosomal region 12q15 that is focally amplified in 12.5% of HGSOC. We found that FRS2 amplified cancer cell lines are dependent on FRS2 expression and that FRS2 overexpression in immortalized human cell lines conferred the ability to grow in an anchorage independent manner and as tumors in immunodeficient mice. FRS2, an adaptor protein in the FGFR pathway, induces downstream activation of Ras-MAPK pathway.
    [Show full text]
  • Caenorhabditis Elegans Fibroblast Growth Factor Receptor Signaling Can Occur Independently of the Multi-Substrate Adaptor FRS2
    Copyright Ó 2010 by the Genetics Society of America DOI: 10.1534/genetics.109.113373 Caenorhabditis elegans Fibroblast Growth Factor Receptor Signaling Can Occur Independently of the Multi-Substrate Adaptor FRS2 Te-Wen Lo,*,1 Daniel C. Bennett,*,2 S. Jay Goodman† and Michael J. Stern*,3 *Department of Genetics and †Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06520-8005 Manuscript received December 21, 2009 Accepted for publication March 14, 2010 ABSTRACT The components of receptor tyrosine kinase signaling complexes help to define the specificity of the effects of their activation. The Caenorhabditis elegans fibroblast growth factor receptor (FGFR), EGL-15, regulates a number of processes, including sex myoblast (SM) migration guidance and fluid homeostasis, both of which require a Grb2/Sos/Ras cassette of signaling components. Here we show that SEM-5/Grb2 can bind directly to EGL-15 to mediate SM chemoattraction. A yeast two-hybrid screen identified SEM-5 as able to interact with the carboxy-terminal domain (CTD) of EGL-15, a domain that is specifically required for SM chemoattraction. This interaction requires the SEM-5 SH2-binding motifs present in the CTD (Y 1009 and Y 1087), and these sites are required for the CTD role of EGL-15 in SM chemoattraction. SEM-5, but not the SEM-5 binding sites located in the CTD, is required for the fluid homeostasis function of EGL-15, indicating that SEM-5 can link to EGL-15 through an alternative mechanism. The multi-substrate adaptor protein FRS2 serves to link vertebrate FGFRs to Grb2.
    [Show full text]